Classification Of Acute Lymphoblastic Leukemia
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 11,196
- 试验地点
- 200
- 主要终点
- Development of a classification guide to help determine patient assignment to a specific treatment clinical trial for newly diagnosed acute lymphoblastic leukemia (ALL)
研究概览
简要总结
This clinical trial is studying risk-group classification of patients with newly diagnosed acute lymphoblastic leukemia. Developing a risk-group classification guide may help doctors assign patients with newly diagnosed acute lymphoblastic leukemia to treatment clinical trials.
详细描述
OBJECTIVES:
I. Provide a classification guide that will organize the clinical and laboratory data necessary for assigning each patient with newly diagnosed acute lymphoblastic leukemia (ALL) to a specific treatment clinical trial.
II. Provide an administrative base to capture classification data for correlative studies accompanying current Children's Oncology Group (COG) ALL treatment clinical trials.
III. Provide a central reference guide for all required and research only ALL studies that will be conducted at local and reference laboratories.
IV. Provide a mechanism for optional banking of leukemia and germline specimens for current and future research.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 1 Year 至 30 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Newly diagnosed acute lymphoblastic leukemia, defined by any of the following:
- •At least 25% blasts in the bone marrow
- •Absolute blast count at least 10,000/mm^3, if bone marrow aspiration is not performed
- •No prior registration on this study
排除标准
- 未提供
结局指标
主要结局
Development of a classification guide to help determine patient assignment to a specific treatment clinical trial for newly diagnosed acute lymphoblastic leukemia (ALL)
时间窗: Up to 5 years
Development of a classification database for correlative studies
时间窗: Up to 5 years
Development of a central reference guide for all required and research only ALL studies
时间窗: Up to 5 years
Development of a leukemia and germline specimen bank for current and future research
时间窗: Up to 5 years
次要结局
未报告次要终点